AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35575766 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane at 1 MAC
Number of subjects: 80
Study 35575766 — intervention group
Group type: COMPARATOR
Intervention: Propofol‐remifentanil total intravenous anesthesia alone
Number of subjects: 80
Study 33453621 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for diagnosing malnutrition
Number of subjects: 1219
Study 33453621 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic tree for malnutrition
Number of subjects: 1219
Study 33453621 — intervention group
Group type: EXPERIMENTAL
Intervention: Classification tree for grading malnutrition
Number of subjects: 1219
Study 33453621 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss within 6 months
Number of subjects: 1219
Study 32379982 — intervention group
Group type: EXPERIMENTAL
Intervention: Wii™ (exergames) group, n=16
Number of subjects: 35
Study 32379982 — intervention group
Group type: COMPARATOR
Intervention: Stretching exercises (control group), n=19
Number of subjects: 35
Study 35587574 — intervention group
Group type: EXPERIMENTAL
Intervention: ArtemiC oral spray, twice daily on Days 1 and 2, beside standard care
Number of subjects: 50
Study 35587574 — intervention group
Group type: COMPARATOR
Intervention: Placebo oral spray, twice daily on Days 1 and 2, beside standard care
Number of subjects: 50
Study 35587574 — intervention group
Group type: EXPERIMENTAL
Intervention: ArtemiC
Number of subjects: 50
Study 34536714 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Anxiety Sensitivity Treatment (CAST)
Number of subjects: 105
Study 33029528 — intervention group
Group type: EXPERIMENTAL
Intervention: PNF stretching technique combined with TENS
Number of subjects: 60
Study 33029528 — intervention group
Group type: EXPERIMENTAL
Intervention: PNF stretching technique alone
Number of subjects: 60
Study 33029528 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 60
Study 34028012 — intervention group
Group type: EXPERIMENTAL
Intervention: Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE), FIO2 1.0, 70 L min−1 during apnoea
Number of subjects: 30
Study 34028012 — intervention group
Group type: COMPARATOR
Intervention: Mechanical Ventilation (MV)
Number of subjects: 30
Study 32503652 — intervention group
Group type: EXPERIMENTAL
Intervention: Dill powder supplementation (3 g/day)
Number of subjects: 42
Study 33957178 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban plus aspirin
Number of subjects: 18278
Study 33957178 — intervention group
Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 18278
Study 34049922 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide 2 mg weekly
Number of subjects: 200
Study 34049922 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 33415871 — intervention group
Group type: COMPARATOR
Intervention: Traditional pricking-cupping (TP-C)
Number of subjects: 96
Study 33415871 — intervention group
Group type: COMPARATOR
Intervention: Rolling needle pricking-cupping (RNP-C)
Number of subjects: 96
Study 33415871 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture (EA)
Number of subjects: 96
Study 32107975 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Observation of Procedural Skills (DOPS) and Mini‐Clinical Evaluation Exercise (Mini‐CEX)
Number of subjects: 108
Study 32107975 — intervention group
Group type: EXPERIMENTAL
Intervention: DOPS and Mini‐CEX
Number of subjects: 108
Study 35697440 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal medial branch nerve block (MBNB)
Number of subjects: 0
Study 35697440 — intervention group
Group type: COMPARATOR
Intervention: Vertebroplasty (VP)
Number of subjects: 0
Study 33446039 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D‐MOT training (twice per week for 12 weeks)
Number of subjects: 33
Study 33446039 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 33
Study 35949922 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab (40 mg in 0.4 mL), four injections every 3 months
Number of subjects: 140
Study 35949922 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo), four injections every 3 months
Number of subjects: 140
Study 33436300 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic Manipulative Treatment (OMT)
Number of subjects: 23
Study 33436300 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 23
Study 35395932 — intervention group
Group type: EXPERIMENTAL
Intervention: App-based intervention designed to support voluntary commitment to abstain from or reduce substance or digital media use over a period of 2 weeks.
Number of subjects: 4500
Study 35395932 — intervention group
Group type: EXPERIMENTAL
Intervention: App-based intervention
Number of subjects: 4500
Study 35395932 — intervention group
Group type: COMPARATOR
Intervention: Education-as-usual control arm (waitlist control)
Number of subjects: 4500
Study 33592011 — intervention group
Group type: COMPARATOR
Intervention: Urban dwelling
Number of subjects: 528
Study 33592011 — intervention group
Group type: COMPARATOR
Intervention: Fasting blood glucose level between 203 and 282
Number of subjects: 528
Study 33592011 — intervention group
Group type: COMPARATOR
Intervention: Fasting blood glucose level 282 and above
Number of subjects: 528
Study 33592011 — intervention group
Group type: COMPARATOR
Intervention: Duration of diabetes mellitus for 10 and more years
Number of subjects: 528
Study 33592011 — intervention group
Group type: COMPARATOR
Intervention: Controlling glucose level after developing symptoms
Number of subjects: 528
Study 33592011 — intervention group
Group type: COMPARATOR
Intervention: Having high blood pressure
Number of subjects: 528
Study 33592011 — intervention group
Group type: COMPARATOR
Intervention: Family history of complication from diabetes mellitus
Number of subjects: 528
Study 33592011 — intervention group
Group type: COMPARATOR
Intervention: Exercising 3 times per week for 15 to 30 minutes
Number of subjects: 528
Study 33592011 — intervention group
Group type: COMPARATOR
Intervention: Exercising for less than 15 minutes
Number of subjects: 528
Study 33592011 — intervention group
Group type: COMPARATOR
Intervention: Waist circumference greater than or equal to 40 inches
Number of subjects: 528
Study 34995927 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-Family Partnership (NFP) program
Number of subjects: 47
Study 34342086 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine and temozolomide (CAPTEM)
Number of subjects: 130
Study 35072661 — intervention group
Group type: EXPERIMENTAL
Intervention: gymnastics + NMT (gNMT; n = 16)
Number of subjects: 43
Study 35072661 — intervention group
Group type: EXPERIMENTAL
Intervention: gymnastics only (GYM; n = 15)
Number of subjects: 43
Study 35072661 — intervention group
Group type: COMPARATOR
Intervention: maturity-matched control (CON; n = 12)
Number of subjects: 43
Study 32601665 — intervention group
Group type: EXPERIMENTAL
Intervention: PRESTO‐Play
Number of subjects: 0
Study 32601665 — intervention group
Group type: COMPARATOR
Intervention: PRESTO‐Fit
Number of subjects: 0
Study 33570701 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 50,000 IU PO weekly for 12 weeks
Number of subjects: 80
Study 33570701 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 33270145 — intervention group
Group type: EXPERIMENTAL
Intervention: Juul EU (20 mg/ml)
Number of subjects: 18
Study 33270145 — intervention group
Group type: COMPARATOR
Intervention: Juul US (59 mg/ml)
Number of subjects: 18
Study 33270145 — intervention group
Group type: COMPARATOR
Intervention: OBC
Number of subjects: 18
Study 32416072 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivosidenib 500 mg once daily
Number of subjects: 185
Study 32416072 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 185
Study 32416072 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivosidenib
Number of subjects: 185
Study 34776029 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye masks intervention for three nights after tracheal intubation removal
Number of subjects: 40
Study 34776029 — intervention group
Group type: COMPARATOR
Intervention: Routine sleep care (Control)
Number of subjects: 40
Study 33264063 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 risk mitigation plan implemented during Hajj 2020
Number of subjects: 1000
Study 32725791 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% CO2-enriched gas mixture (8% oxygen + 3% CO2)
Number of subjects: 20
Study 32725791 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% CO2-enriched gas mixture (8% oxygen + 5% CO2)
Number of subjects: 20
Study 32725791 — intervention group
Group type: COMPARATOR
Intervention: Pure hypoxic gas (8% oxygen)
Number of subjects: 20
Study 35377723 — intervention group
Group type: EXPERIMENTAL
Intervention: YEARS rule + D-dimer
Number of subjects: 0
Study 35377723 — intervention group
Group type: COMPARATOR
Intervention: D-dimer alone
Number of subjects: 0
Study 34505019 — intervention group
Group type: EXPERIMENTAL
Intervention: rhTPO plus GCSF
Number of subjects: 30
Study 34505019 — intervention group
Group type: COMPARATOR
Intervention: GCSF alone
Number of subjects: 30
Study 34050857 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Therapy for Suicide Prevention + treatment as usual (CTSP + TAU) (N=75)
Number of subjects: 150
Study 34050857 — intervention group
Group type: COMPARATOR
Intervention: treatment as usual (TAU) alone (N=75)
Number of subjects: 150
Study 34968972 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiphase Optimization Strategy (MOST)
Number of subjects: 0
Study 34968972 — intervention group
Group type: EXPERIMENTAL
Intervention: Factorial experiment
Number of subjects: 0
Study 34968972 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential Multiple-Assignment Randomized Trial (SMART)
Number of subjects: 0
Study 32493066 — intervention group
Group type: EXPERIMENTAL
Intervention: Concussion Coach cell phone application
Number of subjects: 35
Study 34259369 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold lateral compaction
Number of subjects: 45
Study 34259369 — intervention group
Group type: COMPARATOR
Intervention: Continuous-wave obturation
Number of subjects: 45
Study 34259369 — intervention group
Group type: COMPARATOR
Intervention: New generation thermoplastic core carrier
Number of subjects: 45
Study 33986878 — intervention group
Group type: EXPERIMENTAL
Intervention: Booklet
Number of subjects: 160
Study 33986878 — intervention group
Group type: EXPERIMENTAL
Intervention: Booklet + Oral Presentation
Number of subjects: 160
Study 33986878 — intervention group
Group type: EXPERIMENTAL
Intervention: Booklet + Oral Presentation + Clinical Teaching
Number of subjects: 160
Study 33986878 — intervention group
Group type: COMPARATOR
Intervention: Routine Education
Number of subjects: 160
Study 32430272 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard suction
Number of subjects: 300
Study 32430272 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow-pull suction
Number of subjects: 300
Study 32430272 — intervention group
Group type: EXPERIMENTAL
Intervention: Wet suction
Number of subjects: 300
Study 34351822 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual visits for cancer care
Number of subjects: 21362
Study 34351822 — intervention group
Group type: COMPARATOR
Intervention: In-person visits for cancer care
Number of subjects: 21362
Study 34351822 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual visits
Number of subjects: 21362
Study 33021606 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral prednisolone (15 mg twice daily for 2 weeks, followed by clarithromycin [500 mg daily] for 12 weeks)
Number of subjects: 126
Study 33021606 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 14 weeks
Number of subjects: 126
Study 33021606 — intervention group
Group type: COMPARATOR
Intervention: Oral prednisolone (15 mg twice daily for 2 weeks, followed by placebo for 12 weeks)
Number of subjects: 126
Study 32730905 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban (2.5 mg twice daily) plus aspirin (100 mg once daily) for 12 months
Number of subjects: 200
Study 32730905 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (75 mg daily) for at least 3 months on a background of aspirin (100 mg once daily) for 12 months
Number of subjects: 200
Study 34212177 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider-targeted intervention including education on appropriate RTD prescribing and monthly peer comparison feedback.
Number of subjects: 185755
Study 34212177 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider-targeted intervention for tier 2 RTDs.
Number of subjects: 185755
Study 34212177 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider-targeted intervention for tier 3 RTDs.
Number of subjects: 185755
Study 34212177 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider-targeted intervention for tier 1 RTDs.
Number of subjects: 185755
Study 34000295 — intervention group
Group type: EXPERIMENTAL
Intervention: Immersive seminar
Number of subjects: 26
Study 34000295 — intervention group
Group type: COMPARATOR
Intervention: Traditional lecture
Number of subjects: 26
Study 32541462 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine transdermal patch (BTP) 10 mg for 14 days
Number of subjects: 160
Study 32541462 — intervention group
Group type: COMPARATOR
Intervention: Conventional analgesic regimen (IV paracetamol 1 mg every 8 hours alternating with parenteral tramadol 50 mg every 8 hours for the first 2 postoperative days, followed by oral administration of the same drug until the end of 2 weeks)
Number of subjects: 160
Study 35305278 — intervention group
Group type: EXPERIMENTAL
Intervention: HEAT (5 × 50 min weekly heat suit training sessions)
Number of subjects: 25
Study 35305278 — intervention group
Group type: COMPARATOR
Intervention: CON (matched for training volume and intensity distribution)
Number of subjects: 25
Study 32781256 — intervention group
Group type: EXPERIMENTAL
Intervention: iliac bone graft along with injectable and advanced platelet rich fibrin
Number of subjects: 30
Study 32781256 — intervention group
Group type: COMPARATOR
Intervention: iliac bone graft alone
Number of subjects: 30
Study 33861738 — intervention group
Group type: EXPERIMENTAL
Intervention: SNPs analysis for IL37 rs2723186
Number of subjects: 116
Study 33861738 — intervention group
Group type: EXPERIMENTAL
Intervention: SNPs analysis for IL10 rs1800872
Number of subjects: 116
Study 33861738 — intervention group
Group type: EXPERIMENTAL
Intervention: SNPs analysis for IL10 rs3024496
Number of subjects: 116
Study 34627636 — intervention group
Group type: EXPERIMENTAL
Intervention: Job advertisement posters emphasizing future career prospects
Number of subjects: 0
Study 34627636 — intervention group
Group type: COMPARATOR
Intervention: Standard recruitment process without career emphasis
Number of subjects: 0
Study 32289791 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 0
Study 35238765 — intervention group
Group type: EXPERIMENTAL
Intervention: MIV-711 100 mg
Number of subjects: 119
Study 35238765 — intervention group
Group type: EXPERIMENTAL
Intervention: MIV-711 200 mg
Number of subjects: 119
Study 35238765 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study 32434362 — intervention group
Group type: EXPERIMENTAL
Intervention: Plum blossom needle acupuncture with qi-invigorating superficies-consolidating therapy
Number of subjects: 87
Study 32434362 — intervention group
Group type: COMPARATOR
Intervention: Conventional Western medicine
Number of subjects: 87
Study 36185308 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive radical antegrade modular pancreatosplenectomy (MI-RAMPS)
Number of subjects: 250
Study 36185308 — intervention group
Group type: COMPARATOR
Intervention: Open radical antegrade modular pancreatosplenectomy (open RAMPS)
Number of subjects: 250
Study 33992812 — intervention group
Group type: EXPERIMENTAL
Intervention: NaOCl/EDTA with PDT (Curcumin‐PS‐CP)
Number of subjects: 60
Study 33992812 — intervention group
Group type: COMPARATOR
Intervention: NaOCl/EDTA
Number of subjects: 60
Study 33992812 — intervention group
Group type: COMPARATOR
Intervention: Sealapex (Gp 3 and Gp 4)
Number of subjects: 60
Study 33992812 — intervention group
Group type: EXPERIMENTAL
Intervention: MTA Fillapex (Gp 5 and Gp 6)
Number of subjects: 60
Study 33992812 — intervention group
Group type: EXPERIMENTAL
Intervention: MTA Fillapex with PDT (Gp 6)
Number of subjects: 60
Study 35477413 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative Exposure Therapy for Children (KIDNET)
Number of subjects: 0
Study 35477413 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study 34392492 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous metoclopramide (Gr.A)
Number of subjects: 83
Study 34392492 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (Gr.B)
Number of subjects: 83
Study 34392492 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Gr.C)
Number of subjects: 83
Study 34392492 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide (Gr.A)
Number of subjects: 83
Study 34392492 — intervention group
Group type: EXPERIMENTAL
Intervention: Resolution of FI within 72-h
Number of subjects: 83
Study 33558193 — intervention group
Group type: EXPERIMENTAL
Intervention: Osimertinib 80 mg once daily
Number of subjects: 0
Study 33558193 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33602325 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity treadmill exercise (20 min, 70–75% of their maximal heart rate)
Number of subjects: 103
Study 33602325 — intervention group
Group type: COMPARATOR
Intervention: Seated rest (20 min)
Number of subjects: 103
Study 33602325 — intervention group
Group type: EXPERIMENTAL
Intervention: Trier Social Stress Test for Children (14 min)
Number of subjects: 103
Study 32318103 — intervention group
Group type: EXPERIMENTAL
Intervention: Real TBS and real RHI
Number of subjects: 22
Study 32318103 — intervention group
Group type: COMPARATOR
Intervention: Sham TBS and real RHI
Number of subjects: 22
Study 32318103 — intervention group
Group type: COMPARATOR
Intervention: Sham TBS and sham RHI
Number of subjects: 22
Study 32318103 — intervention group
Group type: EXPERIMENTAL
Intervention: Real TBS and sham RHI
Number of subjects: 22
Study 33481251 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute intravenous glucose-induced hyperglycaemia
Number of subjects: 0
Study 33481251 — intervention group
Group type: COMPARATOR
Intervention: Octreotide-maintained euglycaemia
Number of subjects: 0
Study 32509972 — intervention group
Group type: EXPERIMENTAL
Intervention: STAR (augmented reality telementoring platform)
Number of subjects: 0
Study 32509972 — intervention group
Group type: COMPARATOR
Intervention: Remote audio-only guidance
Number of subjects: 0
Study 616649626 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticipatory processing prior to a threat of a speech task
Number of subjects: 100
Study 616649626 — intervention group
Group type: COMPARATOR
Intervention: Control condition with no social evaluative threat
Number of subjects: 100
Study 36126236 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (4-month training, 60 min/session, 3 d/wk)
Number of subjects: 150
Study 36126236 — intervention group
Group type: COMPARATOR
Intervention: Counseling group (attended conferences on healthy lifestyle)
Number of subjects: 150
Study 33495489 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 hours of head-down bed rest (HDBR)
Number of subjects: 14
Study 33495489 — intervention group
Group type: COMPARATOR
Intervention: Control (pre-HDBR)
Number of subjects: 14
Study 33036887 — intervention group
Group type: EXPERIMENTAL
Intervention: CLADS-driven propofol TIVA
Number of subjects: 0
Study 33036887 — intervention group
Group type: COMPARATOR
Intervention: Manual controlled propofol TIVA
Number of subjects: 0
Study 34751757 — intervention group
Group type: EXPERIMENTAL
Intervention: Early surgical treatment within 24 hours after admission
Number of subjects: 70
Study 34751757 — intervention group
Group type: COMPARATOR
Intervention: Delayed surgical treatment after at least 2 weeks of conservative treatment
Number of subjects: 70
Study 34751757 — intervention group
Group type: EXPERIMENTAL
Intervention: Early surgical treatment
Number of subjects: 70
Study 34751757 — intervention group
Group type: COMPARATOR
Intervention: Delayed surgical treatment
Number of subjects: 70
Study 35049436 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical pharmacist intervention (patient counselling, patient information leaflet)
Number of subjects: 88
Study 35049436 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 88
Study 34290294 — intervention group
Group type: EXPERIMENTAL
Intervention: FLNA
Number of subjects: 269
Study 34290294 — intervention group
Group type: EXPERIMENTAL
Intervention: CLU
Number of subjects: 269
Study 34290294 — intervention group
Group type: EXPERIMENTAL
Intervention: CAP1
Number of subjects: 269
Study 34290294 — intervention group
Group type: EXPERIMENTAL
Intervention: FLNA and CLU combination
Number of subjects: 269
Study 34290294 — intervention group
Group type: COMPARATOR
Intervention: FLNA and CLU combination (with hepatic fibrosis and non-alcoholic fatty liver as control)
Number of subjects: 269
Study 35460915 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive behavioral intervention for weight management and glycemia optimization
Number of subjects: 0
Study 35460915 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient mechanistic phase
Number of subjects: 0
Study 35460915 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient behavioral phase
Number of subjects: 0
Study 32727192 — intervention group
Group type: EXPERIMENTAL
Intervention: Gunsight closure technique
Number of subjects: 143
Study 32727192 — intervention group
Group type: COMPARATOR
Intervention: Purse-string closure technique
Number of subjects: 143
Study 34030579 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates exercise group (PEG)
Number of subjects: 20
Study 35502002 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-reminiscence therapy (CRT)
Number of subjects: 62
Study 35502002 — intervention group
Group type: COMPARATOR
Intervention: Wait-list (Control)
Number of subjects: 62
Study 34590570 — intervention group
Group type: EXPERIMENTAL
Intervention: Senling Baizhu san (SLBZS) 100 mL, twice a day, for 12 weeks
Number of subjects: 80
Study 34590570 — intervention group
Group type: COMPARATOR
Intervention: Conventional Western medicine
Number of subjects: 80
Study 34590570 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (SLBZS and control)
Number of subjects: 80
Study 36220354 — intervention group
Group type: EXPERIMENTAL
Intervention: FFR-guided PCI
Number of subjects: 452
Study 36220354 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 452